Abstract
Crossover studies with continuous variables are routinely used in clinical drug research: for example, no less than 22% of the double-blind placebo-controlled hypertension trials in 1993 were accordingly designed (Niemeyer et al. 1998). A major advantage of the crossover design is that it eliminates between-subject variability of symptoms. However, problems include the occurrence of carryover effect, sometimes wrongly called treatment-by-period interaction (see also Chap. 17): if the effect of the first period carries on into the next one, then it may influence the response to the latter period. Second, the possibility of time effects due to external factors such as the change of the seasons has to be taken into account in lengthy crossover studies. Third, negative correlations between drug responses, although recently recognized in clinical pharmacology, is an important possibility not considered in the design and analysis of clinical trials so far. Many crossover studies may have a positive correlation-between-drug-response, not only because treatments in a given comparison are frequently from the same class of drugs, but also because one subject is used for comparisons of two treatments. Still, in treatment comparisons of completely different treatments patients may fall into different populations, those who respond better to the test-treatment and those who do so to the reference-treatment. This phenomenon has already lead to treatment protocols based on individualized rather than stepped care (Scheffé 1959). Power analyses for crossover studies with continuous variables so far only accounted for the possibility of approximately zero levels of correlations (Cleophas 1993; Willan and Pater 1986; Freeman 1989; Fleiss 1989; Senn 1994; Grieve 1994). While considering different levels of correlation, we recently demonstrated (Cleophas and Van Lier 1996) that the crossover design with binary variables is a powerful means of determining the efficacy of new drugs in spite of such factors as carryover effects. Crossover trials with continuous variables, however, have not yet been similarly studied.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Cleophas TJ (1993) Crossover studies: a modified analysis with more power. Clin Pharmacol Ther 53:515–520
Cleophas TJ, Van Lier HH (1996) Clinical trials with binary responses: power analyses. J Clin Pharmacol 36:198–204
Fleiss JA (1989) A critique of recent research on the two-treatment crossover design. Control Clin Trials 10:237–241
Freeman PR (1989) The performance of the two-stage analysis of two-treatment, two-period crossover trials. Stat Med 8:1421–1432
Grieve AP (1994) Bayesian analyses of two-treatment crossover studies. Stat Methods Med Res 3:407–429
Grizzle JE (1965) The two-period change-over design and its use in clinical trials. Biometrics 22:469–480
Hays WL (1988) Statistics, 4th edn. Holt, Rinehart and Winston, Inc, Fort Worth
Niemeyer MG, Zwinderman AH, Cleophas TJ, De Vogel EM (1998) Crossover studies are a better format for comparing equivalent treatments than parallel-group studies. In: Kuhlmann J, Mrozikiewicz A (eds) What should a clinical pharmacologist know to start a clinical trial (phase I and II). Zuckschwerdt Verlag, Munich, pp 40–48
Nies AS, Spielberg SP (1996) Individualization of drug therapy. In: Hardman JL et al (eds) Goodman and Gilman’s pharmacological basis of therapeutics. McGraw-Hill, New York, pp 43–63
Scheffé H (1959) Mixed models. In: Scheffé H (ed) The analysis of variance. Wiley, New York, pp 261–291
Senn S (1994) The AB/BA crossover: past, present and future. Stat Methods Med Res 3:303–324
SPSS for Windows. www.SPSS.com. Accessed 15 Dec 2011
Willan AR, Pater JL (1986) Carryover and the two-period crossover clinical trial. Biometrics 42:593–599
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Cleophas, T.J., Zwinderman, A.H. (2012). Crossover Studies with Continuous Variables. In: Statistics Applied to Clinical Studies. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2863-9_35
Download citation
DOI: https://doi.org/10.1007/978-94-007-2863-9_35
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2862-2
Online ISBN: 978-94-007-2863-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)